Quick Takeaways
- Shameek Konar filed SCHEDULE 13G for Ernexa Therapeutics Inc. Common Stock, par value $0.005 per share (ERNA).
- Disclosed ownership: 5.5%.
- Date of event: 31 Mar 2025.
Shameek Konar - 31 Mar 2025 SCHEDULE 13G Report for Ernexa Therapeutics Inc. Common Stock, par value $0.005 per share (ERNA)
- Filing Manager
- Shameek Konar
- Reporting Manager
- Shameek Konar
- Symbol
- ERNA
- Shares outstanding
- 62,460,073 shares
- Disclosed Ownership
- 3,435,304 shares
- Ownership
- 5.5%
- Form type
- SCHEDULE 13G
- Filing time
- 15 May 2025, 16:42:18 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Shameek Konar disclosed 5.5% ownership in Ernexa Therapeutics Inc. Common Stock, par value $0.005 per share (ERNA) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 May 2025, 16:42.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Shameek Konar | 5.5% | 3,435,304 | 0 | 3,435,304 | /s/ Shameek Konar | Shameek Konar | |
| Victoria Konar | 5.5% | 3,435,304 | 0 | 3,435,304 | /s/ Victoria Konar | Victoria Konar | |
| Regolith Capital Investments LP | 5.4% | 3,343,192 | 0 | 3,343,192 | /s/ Shameek Konar | Shameek Konar/General Partner |